(RNAC) Cartesian Therapeutics - Performance -25.7% in 12m
RNAC performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-79.07%
#132 in Peer-Group
Rel. Strength
19.99%
#6131 in Stock-Universe
Total Return 12m
-25.67%
#84 in Peer-Group
Total Return 5y
-81.27%
#93 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | 2.13 |
| P/E Forward | 25.5 |
| High / Low | USD |
|---|---|
| 52 Week High | 25.14 USD |
| 52 Week Low | 8.77 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 91.69 |
| Buy/Sell Signal +-5 | 0.38 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: RNAC (-25.7%) vs XBI (-12.9%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-0.31% | 59.8% | 74.7% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
4.3% | -9.7% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
0.02% | -7.68% | 38% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-1.08% | 26.2% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.29% | -9.49% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
12.7% | 37.9% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-5.29% | 46.5% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
0.46% | 28.5% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: RNAC vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for RNAC
| Total Return (including Dividends) | RNAC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 27.83% | 4.10% | 4.77% |
| 3 Months | 2.46% | 13.70% | 16.02% |
| 12 Months | -25.67% | -12.86% | 12.44% |
| 5 Years | -81.27% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | RNAC | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 79.5% | 52.1% | 90.3% |
| 3 Months | -8.6% | 79.4% | 97.5% |
| 12 Months | -49.2% | -87.4% | 46.4% |
| 5 Years | -90.7% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th90.00 | 22.80% | 22.01% |
| 3 Month | %th30.50 | -9.89% | -11.68% |
| 12 Month | %th58.00 | -14.70% | -33.89% |
| 5 Years | %th56.00 | -76.00% | -91.19% |
FAQs
Does Cartesian Therapeutics (RNAC) outperform the market?
No,
over the last 12 months RNAC made -25.67%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.86%.
Over the last 3 months RNAC made 2.46%, while XBI made 13.70%.
Performance Comparison RNAC vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
RNAC vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 23.2% | 23.1% | -35.2% | -38% |
| US NASDAQ 100 | QQQ | 23.3% | 22.5% | -37.2% | -38% |
| German DAX 40 | DAX | 22.9% | 24.7% | -47.4% | -55% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 22% | 22.7% | -39.7% | -45% |
| Hongkong Hang Seng | HSI | 22.3% | 23.9% | -57.2% | -60% |
| India NIFTY 50 | INDA | 24.6% | 26.3% | -35.7% | -22% |
| Brasil Bovespa | EWZ | 27.4% | 28.2% | -50.3% | -26% |
RNAC vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 24.6% | 24.2% | -38.5% | -49% |
| Consumer Discretionary | XLY | 22.3% | 23% | -27.5% | -42% |
| Consumer Staples | XLP | 25.3% | 27.3% | -34.3% | -33% |
| Energy | XLE | 20.3% | 25.8% | -27.7% | -26% |
| Financial | XLF | 24.7% | 23.1% | -37.6% | -49% |
| Health Care | XLV | 23.1% | 28.1% | -23.7% | -19% |
| Industrial | XLI | 22.8% | 22.2% | -41.1% | -48% |
| Materials | XLB | 22.5% | 22.6% | -35.9% | -29% |
| Real Estate | XLRE | 23.5% | 27.7% | -33.7% | -33% |
| Technology | XLK | 23.3% | 20.7% | -40.3% | -36% |
| Utilities | XLU | 23.1% | 25.9% | -39.3% | -48% |
| Aerospace & Defense | XAR | 22.6% | 20.6% | -55.2% | -73% |
| Biotech | XBI | 19.6% | 23.7% | -25% | -13% |
| Homebuilder | XHB | 20.1% | 16.5% | -28.7% | -23% |
| Retail | XRT | 23.3% | 21% | -30.4% | -32% |
RNAC vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 22.6% | 31.5% | -21.3% | -22% |
| Natural Gas | UNG | 24.9% | 36.6% | -9.2% | -29% |
| Gold | GLD | 23.1% | 30.1% | -53.1% | -64% |
| Silver | SLV | 18.9% | 21.6% | -57.3% | -51% |
| Copper | CPER | 12.9% | 11.9% | -54.8% | -49% |
RNAC vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 24.1% | 28.1% | -29.9% | -22% |
| iShares High Yield Corp. Bond | HYG | 23.8% | 26.5% | -32.2% | -34% |